Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 2/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.32 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8416194 | 0.76 | LMNA (0.36) | HTR2BHTR2A | |
| SCHEMBL8581361 | 0.76 | GPR3 (0.30) | GPR3 | |
| SCHEMBL12429503 | 0.76 | GPR3 (0.38) | GPR3SLC22A2SLC22A3HTR7HTR2B | |
| SCHEMBL358532 | 0.73 | GPR3 (0.39) | GPR3HTR7HTR2BHTR2A | |
| SCHEMBL31338566 | 0.73 | GPR3 (0.39) | GPR3HTR7HTR2BHTR2A | |
| Hydrochloric Acid SCHEMBL28225814 | 0.73 | GPR3 (0.39) | GPR3DRD2DRD4SLC22A2SLC22A3 | |
| SCHEMBL7176731 | 0.72 | — | — | |
| SCHEMBL28807674 | 0.72 | GPR3 (0.38) | GPR3DRD2DRD4SLC22A2SLC22A3 | |
| SCHEMBL30987013 | 0.72 | ALDH1A1 (0.41) | GPR3HTR7HTR2BHTR2APOLB | |
| SCHEMBL29285278 | 0.72 | ALDH1A1 (0.41) | GPR3HTR7HTR2BHTR2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0705851-B9 | Catalyst systems and process for producing broad molecular weight distribution polyolefin | CONOCOPHILLIPS CO (US) | 2004-08-11 | — | — | EP | claimed |
| EP-0705851-B1 | Catalyst systems and process for producing broad molecular weight distribution polyolefin | CONOCOPHILLIPS CO (US) | 2004-01-21 | — | — | EP | claimed |
| US-5594078-A | BRIDGED FLUORENYL METALLOCENE CATALYST | PHILLIPS PETROLEUM COMPANY (US) | 1997-01-14 | — | — | US | claimed |
| US-5534473-A | METALLOCENES AND COCATALYST | PHILLIPS PETROLEUM COMPANY (US) | 1996-07-09 | — | — | US | claimed |
| EP-0705851-A2 | Catalyst systems and process for producing broad molecular weight distribution polyolefin | PHILLIPS PETROLEUM COMPANY (US) | 1996-04-10 | — | — | EP | claimed |
| EP-1852408-B1 | PROCESS FOR THE DIMERIZATION OF ALPHA-OLEFINS | IDEMITSU KOSAN CO (JP) | 2018-04-04 | — | — | EP | disclosed |
| US-20130225892-A1 | PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2013-08-29 | — | — | US | disclosed |
| US-20120088946-A1 | PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| US-8119850-B2 | Process for producing unsaturated hydrocarbon compound | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-21 | — | — | US | disclosed |
| US-20090069614-A1 | METHOD FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20090030255-A1 | PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-1852408-A1 | PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2007-11-07 | — | — | EP | disclosed |
| EP-1849757-A1 | METHOD FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2007-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030255-A1 | PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND | ALOX12, ALOX15B, ALOX15 | GPR3 2942/4885DRD2 978/4885DRD4 818/4885 |
| US-20090069614-A1 | METHOD FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND | AHR, ALOX12, ARNT | GPR3 2030/4885DRD2 1042/4885DRD4 1034/4885 |
| US-20120088946-A1 | PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND | ALOX12, ALOX15B, ALOX15 | GPR3 2942/4885DRD2 978/4885DRD4 818/4885 |
| US-20130225892-A1 | PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND | ALOX12, ALOX15B, ALOX15 | GPR3 2942/4885DRD2 978/4885DRD4 818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.